CEO’s Statement


CEO’s Statement

CEO Ji Hyeon Ju

CiSTEM Co,. Ltd.

Professor, Rheumatology, The Catholic University of Korea, Seoul St. Mary’s Hospital

I’m JiHyeon Ju, CEO of CiSTEM.

CiSTEM is a biotech company that uses induced pluripotent stem cells to produce normal and diseased cell lines, provide platform services for disease modeling, and develop stem cell-based therapeutics. We are developing  various diagnostic and therapeutic pipelines for our patients for one goal only - "Seek for the Sick"

CiSTEM's executives and employees regard "Seek for the Sick", the company's core philosophy, as the most important value.

We are committed to research, development, and application processes to diagnose and treat patients with incurable diseases that cannot be resolved with modern medicine. We have established a strategy to focus on induced pluripotent stem cells among various stem cells. Induced pluripotent stem cells are a material with great potential because of simplicity in cell acquisition and diverse differentiation capabilities. We will develop stem cell therapy that aims at regeneration and functional recovery of aging organs into a promising treatment in this era of ultra-aging society.

Our company is a young company founded in 2017. CiSTEM is a technology-oriented venture company created by the passion of young researchers through transferring the technology developed at Induced Pluripotent Stem Cell Research Center of the Catholic University of Korea College of Medicine.

"Without passion, nothing is gained"

With this passion, CiSTEM aims to grow into a company that contributes to society by conducting R&D of induced pluripotent stem cells for the treatment of patients suffering from incurable diseases. We would be grateful if you follow us with great interest.